(CercleFinance.com) – Valbiotis announced on Friday the success of its capital increase of 15 million euros aimed at enabling it to accelerate the marketing of its food supplement offering.
In a press release, the group based in La Rochelle recalls that the operation was already secured by commitments under the guarantee for a total amount of 11.6 million euros.
The subscription request amounted to 7.9 million euros, including a request of more than 3.9 million euros from existing shareholders, 3.5 million as part of the overall placement and 500,000 euros as part of the public offer.
This fundraising aims to ensure its growth and enable self-financing of its growth, while maintaining its focus on 100% plant-based food supplements.
The group intends in particular to prepare the marketing of Totum.63 (treatment of prediabetes) alongside Nestlé Health Science and initiate the direct marketing of other products in France including Totum.070 (cholesterol reduction).
On the stock market, the stock has posted a gain of more than 31% this year.